Characteristics of study population and seroprevalence of HSV-1 and HSV-2 antibodies
| All patients | Males | Females | |
|---|---|---|---|
| *χ2 test. p Value shows the significant difference between the results in males and females. | |||
| Age: median (range) | 28 (16–66) | 31 (16–66) | 26 (16–65) |
| Education: No. (%) | |||
| ⩾ University education | 74/220 (34%) | 36/105 (34%) | 38/115 (33%) |
| < University education | 146/220 (66%) | 69/105 (66%) | 77/115 (67%) |
| Ethnicity: No (%) | |||
| Caucasian | 189/221 (85%) | 85/106 (80%) | 104/115 (90%) |
| Black | 17/221 (8%) | 12/106 (11%) | 5/115 (4%) |
| Asian | 11/221 (5%) | 7/106 (7%) | 4/115 (3%) |
| Others | 4/221 (2%) | 2/106 (2%) | 2/115 (2%) |
| Occupation: No (%) | |||
| Managerial/professional | 35/219 (16%) | 26/105 (25%) | 9/114 (8%) |
| Skilled non-manual | 31/219 (14%) | 4/105 (4%) | 27/114 (24%) |
| Skilled manual | 13/219 (6%) | 13/105 (12%) | 0 (0%) |
| Unskilled/partially skilled | 60/219 (27%) | 30/105 (29%) | 30/114 (26%) |
| Students | 32/219 (15%) | 11/105 (10%) | 21/114 (18%) |
| Others (unemployed, housewives..) | 48/219 (21%) | 21/105 (20%) | 27/114 (24%) |
| No of lifetime partners: No (%) | |||
| <5 | 86/221 (39%) | 27/106 (25%) | 59/115 (51%) |
| 5–19 | 91/221 (41%) | 45/106 (42%) | 46/115 (40%) |
| ⩾20 | 44/221 (20%) | 34/106 (32%) | 10/115 (9%) |
| Sexual attitude: No (%) | |||
| Heterosexuality: | 214/222 (96%) | 100/106 (94%) | 114/116 (98%) |
| Presenting problem: No (%) | |||
| Genital symptom | 160/221 (72%) | 78/105 (74%) | 82/116 (71%) |
| Check up (asyptomatic) | 61/221 (28%) | 27/105 (26%) | 34/116 (29%) |
| History of genital herpes: No (%) | 30/215 (14%) | 15/103 (15%) | 15/112 (13%) |
| History of current STI: No (%) | 57/218 (26%) | 31/104 (30%) | 26/114 (23%) |
| History of previous STI: No (%) | 74/222 (33%) | 41/106 (39%) | 33/116 (28%) |
| History of drug abuse (ever): No (%) | |||
| Non-injecting: | 72/221 (33%) | 45/106 (42%) | 27/115 (23%) |
| Injecting: | 1/221 (0.4%) | 1/105 (0.9%) | 0/116 (0%) |
| Prevalence: No (%) | |||
| Positive HSV-1 | 129/215 (60%) | 62/104 (60%) | 67/111 (60%) |
| (95% CI) | (53.45 to 66.55) | (50.19 to 69.05) | (51.26 to 69.46) |
| p value* | 0.91 | ||
| Positive HSV-2 | 43/216 (20%) | 19/103 (18%) | 24/113 (21%) |
| (95% CI) | (14.58 to 25.23) | (10.96 to 25.94) | (13.70 to 28.78) |
| p value* | 0.61 | ||
| Positive HSV-1 and HSV-2 | 25/214 (12%) | 11/103 (11%) | 14/111 (13%) |
| (95% CI) | (7.38 to 15.99) | (4.71 to 16.64) | (6.44 to 18.79) |
| p value* | 0.66 | ||
| Negative HSV-1 and HSV-2 | 68/214 (32%) | 34/103 (33%) | 34/111 (31%) |
| (95% CI) | (25.54 to 38.01) | (23.93 to 42.09) | (22.06 to 39.21) |
| p value* | 0.71 | ||